Simplex Trading’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-55,989
| Closed | -$7.18M | – | 9084 |
|
|
2025
Q2 | $7.18M | Buy |
55,989
+51,285
| +1,090% | +$5.33M | ﹤0.01% | 1094 |
|
|
2025
Q1 | $416K | Sell |
4,704
-1,904
| -29% | -$186K | ﹤0.01% | 3591 |
|
|
2024
Q4 | $576K | Buy |
+6,608
| New | +$605K | ﹤0.01% | 3374 |
|
|
2024
Q3 | – | Sell |
-2,724
| Closed | -$271K | – | 8517 |
|
|
2024
Q2 | $293K | Buy |
2,724
+9
| +0.3% | +$901 | ﹤0.01% | 4255 |
|
|
2024
Q1 | $257K | Buy |
+2,715
| New | +$233K | ﹤0.01% | 4575 |
|
|
2023
Q4 | – | Sell |
-20,502
| Closed | -$1.33M | – | 8804 |
|
|
2023
Q3 | $1.03M | Buy |
20,502
+5,978
| +41% | +$319K | ﹤0.01% | 2625 |
|
|
2023
Q2 | $917K | Buy |
14,524
+14,234
| +4,908% | +$774K | ﹤0.01% | 2678 |
|
|
2023
Q1 | $13K | Buy |
+290
| New | +$13.1K | ﹤0.01% | 7294 |
|
|
2022
Q2 | – | Sell |
-2,569
| Closed | -$150K | – | 9984 |
|
|
2022
Q1 | $164K | Buy |
+2,569
| New | +$184K | ﹤0.01% | 5439 |
|
|
2021
Q4 | – | Sell |
-551
| Closed | -$57.6K | – | 10492 |
|
|
2021
Q3 | $48K | Hold |
551
| – | – | ﹤0.01% | 7538 |
|
|
2021
Q2 | $48K | Buy |
+551
| New | +$50.5K | ﹤0.01% | 7676 |
|
|
2021
Q1 | – | Sell |
-508
| Closed | -$50.7K | – | 8847 |
|
|
2020
Q4 | $0 | Buy |
+508
| New | +$53.5K | ﹤0.01% | 8341 |
|
|
2020
Q2 | – | Sell |
-100
| Closed | -$6.76K | – | 7620 |
|
|
2020
Q1 | $5K | Buy |
+100
| New | +$6.43K | ﹤0.01% | 6814 |
|
|
2019
Q4 | – | Sell |
-2,198
| Closed | -$165K | – | 7301 |
|
|
2019
Q3 | $161K | Buy |
+2,198
| New | +$190K | ﹤0.01% | 3790 |
|
|
2018
Q3 | – | Sell |
-4,484
| Closed | -$312K | – | 7415 |
|
|
2018
Q2 | $284K | Buy |
+4,484
| New | +$357K | ﹤0.01% | 3067 |
|
|
2018
Q1 | – | Sell |
-1,284
| Closed | -$111K | – | 6156 |
|
|
2017
Q4 | $96K | Buy |
+1,284
| New | +$90.3K | ﹤0.01% | 1831 |
|
|
2017
Q2 | – | Sell |
-4,106
| Closed | -$174K | – | 6103 |
|
|
2017
Q1 | $164K | Buy |
+4,106
| New | +$147K | 0.01% | 1359 |
|
|
2016
Q4 | – | Sell |
-370
| Closed | -$11.2K | – | 5849 |
|
|
2016
Q3 | $10K | Buy |
370
+294
| +387% | +$7.3K | ﹤0.01% | 3593 |
|
|
2016
Q2 | $1K | Buy |
+76
| New | +$1.38K | ﹤0.01% | 5222 |
|
|
2016
Q1 | – | Sell |
-1,026
| Closed | -$17.8K | – | 5587 |
|
|
2015
Q4 | $27K | Buy |
1,026
+843
| +461% | +$19K | ﹤0.01% | 2435 |
|
|
2015
Q3 | $3K | Buy |
+183
| New | +$5.06K | ﹤0.01% | 4325 |
|
Other funds holding BPMC
IA
HNB
Simplex Trading's BPMC Position: Q3 2025 in Review
Simplex Trading sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 55,989 shares — an estimated $7.18M sold.
Simplex Trading first reported a position in BPMC in Q3 2015 and held it in 21 quarters. The position peaked at $7.18M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Simplex Trading reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 55,989 Blueprint Medicines shares in Q3 2025, an estimated $7.18M.
- Simplex Trading first reported a position in Blueprint Medicines in Q3 2015 and held it in 21 quarters.
- Simplex Trading's Blueprint Medicines position peaked at $7.18M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.